SCHEMBL7491012

SCHEMBL7491012

O=C(Nc1ccc(F)cc1O)Nc1ccccc1Br.O=C(Nc1ccc([N+](=O)[O-])cc1O)Nc1ccccc1Oc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 6/20 0.70
MEN1 O00255 6/20 0.70
KMT2A Q03164 6/20 0.70
CXCR1 P25024 5/20 0.70
TDP1 Q9NUW8 2/20 0.70
HDAC6 Q9UBN7 1/20 0.70
MAPT P10636 8/20 0.52
LMNA P02545 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 2/20 0.52
HTT P42858 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPK1 P28482 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KCNMA1 Q12791 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 1/20 0.43
TRPV1 Q8NER1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3708973 0.89 CXCR1 (0.67) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL7495262 0.88 CXCR2 (0.66) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL5595225 0.84 MEN1 (0.60) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL1110610 0.84 CXCR2 (1.00) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL29733649 0.84 CXCR2 (1.00) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL29493172 0.84 CXCR2 (1.00) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL6921874 0.84 CXCR2 (1.00) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL5594971 0.79 CXCR1 (0.73) CXCR2MEN1KMT2ACXCR1TDP1
SCHEMBL6940403 0.79 MAPT (0.61) MEN1KMT2ATDP1MAPTLMNA
SCHEMBL6943988 0.77 MAPT (0.59) MEN1KMT2ATDP1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0896531-A4 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2002-10-30 EP disclosed
EP-0896531-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-02-17 EP disclosed
WO-1997029743-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1997-08-21 WO disclosed